About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Endocrinology
General Surgery
Hematology
Nephrology
Neurosurgery
Oncology
Oral Maxillofacial
Orthopaedics
Pediatrics
Plastic Surgery
Podiatry
Primary Care
Pulmonology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
Targeting Residual Cardiovascular Risk: Emerging Therapies and Novel Approaches
By
Cleveland Clinic European Society of Cardiology 2016 Symposium
09/2016
1 Comment
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
25:31
Novartis
The War on Heart Failure
Feat.
E. Braunwald
14:15
Scott Solomon
Angiotensin Receptor Neprilysin Inhibition for Heart Failure
23:33
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Treating Heart Failure Patients with ARNI’s – Why, When and How?
Feat.
B. Greenberg
07:16
Novartis
The Importance of Physical Examination in Patients With Heart Failure
Feat.
G. Ewald
22:43
Mount Sinai Advanced Heart Symposium 2016
Chronic Heart Failure Update: Incorporating Sacubatril / Valsartan and I...
Feat.
S. Pinney
22:09
The 8th Annual International Hawaii Symposium on Diagnostic and Therapeutic Modalities in Heart Failure
Managing Side Effects and Drug-Drug Interactions in Heart Failure Patients
07:57
Novartis
An Introduction to Heart Failure
Feat.
J. Januzzi
15:56
Cardiology Fiesta 2018
Update on New Pharmacological Therapy for Heart Failure
Feat.
B. Bozkurt
43:21
Novartis
Heart Failure from Bench to Bedside: The Role of Natriuretic Peptides
Feat.
J. Burnett,
J. Januzzi
19:25
Novartis
Biomarkers in Heart Failure
Feat.
J. Januzzi
06:11
Novartis
Hospitalization: An Opportunity to Optimize Care for Patients with Heart...
Feat.
J. Brown
14:41
Cleveland Clinic Heart and Vascular Institute
Heart Failure Awareness
Feat.
S. Nissen,
R. Starling,
J. Estep
19:50
Piedmont Heart Institute Napa Valley Cardiology Conference
Advanced Heart Failure: What Is It and When to Refer?
08:60
Novartis
Diagnostic and Monitoring Tools and Tests in Heart Failure
Feat.
W. Abraham
25:40
Novartis
The Role of the Kidneys in Heart Failure Progression
Feat.
J. Diez
14:01
Clyde Yancy
ACC/AHA/HFSA Update on New Pharmacological Therapy for Heart Failure
10:08
Novartis
Care Processes in the Hospitalized Patient with Heart Failure
Feat.
G. Mentzer
13:31
James Januzzi
Ivabradine for Chronic Heart Failure
24:22
ASPC 2018 Congress on CVD Prevention
Preventing and Managing Heart Failure – One Size Does Not Fit All
Feat.
B. Bozkurt
21:06
Cardiology Fiesta 2017
Stem Cell Therapy Improves Outcomes in Severe Heart Failure: Hope or Hype
Feat.
T. Henry
